Información del producto
Ibrutinib is an inhibitor of tyrosine kinases, including BTK, ABL1, and PDGFR. It is a racemic mixture of ibrutinib enantiomers that has been shown to be effective against lymphocytic leukemia. Ibrutinib has minimal toxicity in humans and has been shown to be well-tolerated with few side effects. Ibrutinib binds to the active site of BTK, blocking the attachment of ATP and leading to inhibition of downstream signaling pathways that are involved in cell proliferation and survival. The drug also inhibits the activity of other tyrosine kinases such as ABL1 and PDGFR.
Propiedades químicas
Consulta técnica sobre: 3D-LMB56387 Ibrutinib Racemate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
